scholarly article | Q13442814 |
P50 | author | Amylou Dueck | Q79379347 |
P2093 | author name string | Holly Geyer | |
Ruben A Mesa | |||
Robyn Scherber | |||
Blake T Langlais | |||
P2860 | cites work | The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 |
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs | Q36915139 | ||
New molecular genetics in the diagnosis and treatment of myeloproliferative neoplasms. | Q38716316 | ||
Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report | Q40045490 | ||
The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis | Q40265956 | ||
The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients. | Q40463923 | ||
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients | Q48680927 | ||
Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes | Q48793166 | ||
P433 | issue | 2 | |
P921 | main subject | myeloproliferative neoplasm | Q18555039 |
P304 | page(s) | 402-408 | |
P577 | publication date | 2018-07-22 | |
P1433 | published in | Leukemia & Lymphoma | Q6534493 |
P1476 | title | Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life? | |
P478 | volume | 60 |
Search more.